# BIO-key International, Inc. (BKYI) · Edgar & Edgarette company card

> BIO-key International (BKYI) saw revenue fall 14.3% in FY2025 to $6 million, operating margin -115% against a 0.9% median for prepackaged software, equity 61.5% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1019034 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/BKYI) · [JSON](https://www.pops4.com/boards/company/BKYI.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $6M |
| Revenue growth, 1 year | -14.3% |
| Revenue growth per year | 3.8% |
| Operating margin | -115.0% (prior year -57.9%) |
| Net margin | -120.6% |
| Operating cash flow | −$5M |
| Capital spending | $12,012 |
| Free cash flow | −$5M |
| Cash | $3M |
| Long-term debt | — |
| Total assets | $8M |
| Total equity | $5M |
| Equity ÷ assets | 61.5% |
| Return on equity | -140.2% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -56.29 (distress zone)
- Piotroski F: 2 of 9 (weak)
- Beneish M: -3.18 (below the −1.78 line)
- Health Harbor boat: Rotting at the dock · four or more warning signs · filed late annual report notice, late quarterly report notice, auditor change in the last 12 months; operating cash flow was negative; operating loss: a margin of -115.0% in FY2025; revenue is hard to predict: its 80% range is ±51%
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $5.9M (FY2025). Experience: revenue down 14.3% on the year, up 3.8% a year over 4 years; operating margin -115.0%, down from -57.9%. Soundness: equity 61.5% of assets, return on equity -140.2%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $3.0M and $9.2M next year (method v4.1: its own 6-year record of growth weighed at 63% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $2.8M to $10.0M. A statistical range, not company guidance. Against peers (140 filers, $50M+ revenue, services-prepackaged software): operating margin -115.0% against a 0.9% median; growth -14.3% against 13.0%.

Range logged 2026-09-29, receipt 6940604b28a3eaa5, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item NT 10-K Late annual report notice: 1, latest 2026-03-31 ([filing](https://www.sec.gov/Archives/edgar/data/1019034/000143774926010741/0001437749-26-010741-index.htm))
- Item 3.01 Exchange listing notice or transfer: 4, latest 2026-06-10 ([filing](https://www.sec.gov/Archives/edgar/data/1019034/000143774926020203/0001437749-26-020203-index.htm))
- Item NT 10-Q Late quarterly report notice: 1, latest 2026-05-18 ([filing](https://www.sec.gov/Archives/edgar/data/1019034/000143774926017624/0001437749-26-017624-index.htm))
- Item 4.01 Auditor change: 1, latest 2026-07-09 ([filing](https://www.sec.gov/Archives/edgar/data/1019034/000143774926023211/0001437749-26-023211-index.htm))

## Recent filings

- 8-K · filed 2026-10-30 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/1019034/000143774926034242/0001437749-26-034242-index.htm)
- S-1 · filed 2026-10-09 · [filing](https://www.sec.gov/Archives/edgar/data/1019034/000143774926032451/0001437749-26-032451-index.htm)
- 8-K · filed 2026-10-06 · 5.07 Submission of Matters to a Vote of Security Holders; 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1019034/000143774926032237/0001437749-26-032237-index.htm)
- 8-K · filed 2026-10-02 · 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1019034/000143774926031903/0001437749-26-031903-index.htm)
- 8-K · filed 2026-09-08 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1019034/000143774926029849/0001437749-26-029849-index.htm)
- 8-K · filed 2026-08-14 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1019034/000143774926027829/0001437749-26-027829-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001019034.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1019034

## Cite

POPS4, Edgar & Edgarette: BIO-key International, Inc. (BKYI) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/BKYI. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.